Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension

Journal of Human Hypertension

Volumn 24, Issue 5, 2010, Pages 320-326

  Horio, T ^a   Kamide, K ^a   Takiuchi, S ^a   Yoshii, M ^a   Miwa, Y ^a   Matayoshi, T ^a   Yoshihara, F ^a   Nakamura, S ^a   Tokudome, T ^a   Miyata, T ^a   Kawano, Y ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Gene polymorphism; Hypertrophy; Insulin like growth factor; Receptor

Indexed keywords

ADENOSINE; CYTIDINE; SOMATOMEDIN C RECEPTOR;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GEOMETRY; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, IGF TYPE 1;

EID: 77951109222     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.73     Document Type: Article

References (29)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
3. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
4. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13-25.
5. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
6. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A et al. Association of left ventricular hypertrophy with metabolic risk factors: the Hyper- GEN study. J Hypertens 2002; 20: 323-331.
7. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802-1807.
8. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-1721.
9. Tokudome T, Horio T, Yoshihara F, Suga S, Kawano Y, Kohno M et al. Different effects of high glucose and insulin on cultured cardiac myocyte hypertrophy and fibroblast proliferation. Metabolism 2004; 53: 710-715.
10. Straus DS. Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 1984; 5: 356-369.
11. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006; 47: 195-202.
12. Tomiyama M, Horio T, Kamide K, Nakamura S, Yoshihara F, Nakata H et al. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. J Hum Hypertens 2007; 21: 212-219.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618.
14. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Pulmonary venous flow and risk of cardiovascular disease in essential hypertension. J Hypertens 2008; 26: 798-805.
15. Okuda T, Fujioka Y, Kamide K, Kawano Y, Goto Y, Yoshimasa Y et al. Verification of 525 coding SNPs in hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387-394.
16. Yang J, Kamide K, Kokubo Y, Takiuchi S, Tanaka C, Banno M et al. Genetic variations of regulator of Gprotein signaling 2 in hypertensive patients and in the general population. J Hypertens 2005; 23: 1497-1505.
17. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11: 1-3.
18. Tanaka C, Kamide K, Takiuchi S, Miwa Y, Yoshii M, Kawano Y et al. An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
19. Yasuda H, Kamide K, Takiuchi S, Matayoshi T, Hanada H, Kada A et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension. J Hum Hypertens 2007; 21: 883-892.
20. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001; 50: 637-642.
21. Bleumink GS, Rietveld I, Janssen JA, van Rossum EF, Deckers JW, Hofman A et al. Insulin-like growth factor- I gene polymorphism and risk of heart failure (the Rotterdam Study). Am J Cardiol 2004; 94: 384-386.
22. Bleumink GS, Schut AF, Sturkenboom MC, Janssen JA, Witteman JC, van Duijn CM et al. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy. Heart 2005; 91: 239-240.
23. Schut AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, Lamberts SW et al. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 2003; 34: 1623-1627.
24. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349: 2211-2222.
25. Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Cancer Epidemiol Biomarkers Prev 2006; 15: 2461-2466.
26. Garcia J, Ahmadi A, Wonnacott A, Sutcliffe W, Nagga K, Soderkvist P et al. Association of insulin-like growth factor-1 receptor polymorphism in dementia. Dement Geriatr Cogn Disord 2006; 22: 439-444.
27. Lee DO, Jee BC, Ku SY, Suh CS, Kim SH, Choi YM et al. Relationships between the insulin-like growth factor I (IGF-I) receptor gene G3174A polymorphism, serum IGF-I levels, and bone mineral density in postmenopausal Korean women. J Bone Miner Metab 2008; 26: 42-46.
28. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-884.
29. Horio T, Maki T, Kishimoto I, Tokudome T, Okumura H, Yoshihara F et al. Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts. Regul Pept 2005; 124: 65-72.